Business Description
GlobeStar Therapeutics Corporation is a New York-based drug development company focused on bringing new treatment options to patients with multiple sclerosis and other diseases that affect the nervous system. The company holds patents on its drug formulations and is currently working through clinical trials in the United States. It was previously called AngioSoma Inc. before adopting its current name in July 2021.